Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$427,782,750
+$23,924,361 QoQ
Shares Held
1,684,383
+1.9% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#116
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Trust & Banking Corp holds $1,884,441,265 across 11 Drug Manufacturers - General names. JNJ ranks #2 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
448,840 | $538,352,205 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,684,383 | $427,782,750 | |
| 3 | ABBV |
AbbVie Inc.
|
1,038,939 | $261,438,609 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,727,562 | $221,991,717 | |
| 5 | AMGN |
Amgen Inc
|
304,371 | $110,218,826 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,862,476 | $107,315,867 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
813,745 | $102,808,542 | |
| 8 | PFE |
Pfizer Inc
|
3,137,191 | $75,543,558 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $427,782,750 | 1,684,383 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $403,858,389 | 1,652,178 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $343,574,663 | 1,660,182 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $308,588,201 | 1,664,266 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $244,524,032 | 1,600,812 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $256,553,318 | 1,546,993 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $246,180,551 | 1,702,258 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $275,233,627 | 1,698,344 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $261,017,643 | 1,785,835 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $290,063,669 | 1,833,641 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $280,592,028 | 1,790,175 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $288,556,311 | 1,852,689 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $359,506,459 | 2,171,982 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $329,010,285 | 2,122,647 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $368,142,484 | 2,084,022 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $327,299,926 | 2,003,550 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $379,607,264 | 2,138,512 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $338,171,852 | 1,908,096 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $339,619,795 | 1,985,268 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $336,155,305 | 2,081,457 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $354,016,868 | 2,148,943 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $385,644,315 | 2,346,482 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $423,509,894 | 2,691,002 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $406,065,732 | 2,727,470 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $388,586,565 | 2,763,184 | Shares | Sole | 2020-09-11 | |
| 2020-03-31 | $365,500,090 | 2,787,311 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||